12/31/06 LIGAND PHARMACEUTICALS 13G

Company

LIGAND PHARMACEUTICALS INC

Filed

January 29, 2007

Accession Number

0000940394-07-000099

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →